Correlation Between Ligand Pharmaceuticals and Ecopetrol

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ligand Pharmaceuticals and Ecopetrol at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ligand Pharmaceuticals and Ecopetrol into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ligand Pharmaceuticals Tr and Ecopetrol SA ADR, you can compare the effects of market volatilities on Ligand Pharmaceuticals and Ecopetrol and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ligand Pharmaceuticals with a short position of Ecopetrol. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ligand Pharmaceuticals and Ecopetrol.

Diversification Opportunities for Ligand Pharmaceuticals and Ecopetrol

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ligand and Ecopetrol is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Ligand Pharmaceuticals Tr and Ecopetrol SA ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ecopetrol SA ADR and Ligand Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ligand Pharmaceuticals Tr are associated (or correlated) with Ecopetrol. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ecopetrol SA ADR has no effect on the direction of Ligand Pharmaceuticals i.e., Ligand Pharmaceuticals and Ecopetrol go up and down completely randomly.

Pair Corralation between Ligand Pharmaceuticals and Ecopetrol

Assuming the 90 days horizon Ligand Pharmaceuticals is expected to generate 4.74 times less return on investment than Ecopetrol. In addition to that, Ligand Pharmaceuticals is 2.5 times more volatile than Ecopetrol SA ADR. It trades about 0.02 of its total potential returns per unit of risk. Ecopetrol SA ADR is currently generating about 0.25 per unit of volatility. If you would invest  1,019  in Ecopetrol SA ADR on January 19, 2024 and sell it today you would earn a total of  115.00  from holding Ecopetrol SA ADR or generate 11.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy27.27%
ValuesDaily Returns

Ligand Pharmaceuticals Tr  vs.  Ecopetrol SA ADR

 Performance 
       Timeline  
Ligand Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ligand Pharmaceuticals Tr has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Ecopetrol SA ADR 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Ecopetrol SA ADR are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Ecopetrol is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Ligand Pharmaceuticals and Ecopetrol Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ligand Pharmaceuticals and Ecopetrol

The main advantage of trading using opposite Ligand Pharmaceuticals and Ecopetrol positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ligand Pharmaceuticals position performs unexpectedly, Ecopetrol can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ecopetrol will offset losses from the drop in Ecopetrol's long position.
The idea behind Ligand Pharmaceuticals Tr and Ecopetrol SA ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios